William E. Rote, Chief Research Officer at Travere Therapeutics, Inc. (TVTX), sold 6,396 shares at $21.05 ($135K) on 2025-05-05, disclosed to the SEC on 2025-05-05.
Scheduled sale ($135k) by Chief Research Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.05 | 3,198 | $67K | 50.0% |
| 2 | $21.05 | 3,198 | $67K | 50.0% |
| Total | $21.05 avg | 6,396 | $135K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-23 | $356K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $409K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $2.4M | — | Filing → |